- Home
- OHI vs ROIV Comparison
OHI vs ROIV Comparison
Compare OHI & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OHI
- ROIV
- Stock Information
- Founded
- OHI N/A
- ROIV 2014
- Country
- OHI United States
- ROIV United Kingdom
- Employees
- OHI N/A
- ROIV N/A
- Industry
- OHI Real Estate Investment Trusts
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- OHI Real Estate
- ROIV Health Care
- Exchange
- OHI Nasdaq
- ROIV Nasdaq
- Market Cap
- OHI 12.3B
- ROIV 14.0B
- IPO Year
- OHI N/A
- ROIV N/A
- Fundamental
- Price
- OHI $43.97
- ROIV $21.09
- Analyst Decision
- OHI Hold
- ROIV Strong Buy
- Analyst Count
- OHI 9
- ROIV 8
- Target Price
- OHI $43.50
- ROIV $21.19
- AVG Volume (30 Days)
- OHI 1.8M
- ROIV 9.3M
- Earning Date
- OHI 10-30-2025
- ROIV 11-10-2025
- Dividend Yield
- OHI 6.07%
- ROIV N/A
- EPS Growth
- OHI 31.87
- ROIV N/A
- EPS
- OHI 1.80
- ROIV N/A
- Revenue
- OHI $1,150,200,000.00
- ROIV $20,329,000.00
- Revenue This Year
- OHI $12.23
- ROIV N/A
- Revenue Next Year
- OHI $7.97
- ROIV $320.50
- P/E Ratio
- OHI $24.53
- ROIV N/A
- Revenue Growth
- OHI 13.72
- ROIV N/A
- 52 Week Low
- OHI $35.04
- ROIV $8.73
- 52 Week High
- OHI $44.21
- ROIV $21.35
- Technical
- Relative Strength Index (RSI)
- OHI 67.33
- ROIV 80.70
- Support Level
- OHI $41.53
- ROIV $19.79
- Resistance Level
- OHI $44.21
- ROIV $21.35
- Average True Range (ATR)
- OHI 1.05
- ROIV 0.71
- MACD
- OHI 0.37
- ROIV 0.07
- Stochastic Oscillator
- OHI 90.86
- ROIV 92.20
About OHI Omega Healthcare Investors Inc.
Omega Healthcare Investors Inc is a healthcare facility real estate investment trust that invests in the United States real estate markets. Omega's portfolio focuses on long-term healthcare facilities. Omega has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs).
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.